Ambuja Cements (AMBUJACEM) — Board Meeting

Ambuja Cements Limited's board approved Q2 FY2025-26 results with standalone revenue declining 7.3% to ₹5,139.48 crore but PAT surging to ₹1,387.55 crore, primarily driven by a ₹1,179.71 crore tax write-back from favorable reassessment orders. The company completed acquisitions of 72.66% stake in Orient Cement (₹5,903.03 crore) and 99.94% stake in Penna Cement (₹4,298.94 crore), while integrating Adani Cementation and recognizing ₹826.38 crore in excise duty refunds and power tariff credits totaling ₹50 crore.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this board meeting affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 3 November 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 3 November 2025

BHARTIARTL Bharti Airtel Limited Financial Results BRITANNIA Britannia Industries Limited Financial Results BAJAJFINSV Bajaj Finserv Limited Financial Results BEL Bharat Electronics Limited Financial Results ULTRACEMCO UltraTech Cement Limited Corporate Action CANBK Canara Bank Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.